Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sindelar, D. K.
Right arrow Articles by Schwartz, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sindelar, D. K.
Right arrow Articles by Schwartz, M. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 6 1275-1280, Copyright © 1999 by American Diabetes Association


ARTICLES

Low plasma leptin levels contribute to diabetic hyperphagia in rats

DK Sindelar, PJ Havel, RJ Seeley, CW Wilkinson, SC Woods and MW Schwartz
Department of Medicine, University of Washington and Puget Sound VA Health Care System, Seattle, USA.

The adipocyte hormone leptin reduces food intake in normal animals. During uncontrolled type 1 diabetes, plasma leptin levels fall, whereas food intake increases. To test the hypothesis that low leptin levels contribute to diabetic hyperphagia, we investigated the effect on food intake of replacement of leptin at basal plasma concentrations for 7 days in Long-Evans rats with uncontrolled diabetes induced by streptozotocin (STZ). One group of STZ diabetic rats received saline (STZ + Sal) (n = 11), while the other group (STZ + Lep) (n = 15) received a subcutaneous infusion of recombinant rat leptin (100 microg x kg(-1) x day(-1)) via osmotic minipumps. A nondiabetic control group (Con) (n = 11) received saline only. In the STZ + Sal group, plasma leptin levels decreased by 75% (P < 0.05) from 2.4+/-0.5 on the day before STZ/citrate buffer vehicle (Veh) injection (day 0) to 0.6+/-0.2 ng/ml on day 7. In contrast, plasma leptin levels on days 3-7 were comparable to pretreatment values in both the STZ + Lep group (day 0: 2.6+/-0.4 vs. day 7: 2.5+/-0.3 ng/ml, NS) and the Con group (day 0: 3.8+/-0.4 vs. day 7: 2.9+/-1.0 ng/ml, NS). In the STZ + Sal group, daily food intake increased gradually to values 43% above basal by day 7 (day 0: 24+/-2 to day 7: 33+/-3 g, P < 0.05), whereas food intake did not increase in either the STZ + Lep group (day 0: 24+/-1 vs. day 7: 21+/-2 g, NS), or the Con group (day 0: 23+/-1 vs. day 7: 23+/-2 g). Plasma glucose levels exceeded nondiabetic control values (7.7+/-0.2 mmol/l) in both diabetic groups, but were lower in the STZ + Lep group (17.2+/-1.8 mmol/l) than in the STZ + Sal group (24.3+/-1.1 mmol/l, P < 0.05). To determine if sensitivity to leptin-induced anorexia was affected by STZ treatment, a second experiment was performed in which the effect of intracerebroventricular leptin injection (at doses of 0.35, 1.0, or 3.5 microg) on food intake was measured 10 days after STZ or Veh treatment. Leptin suppressed both 4- and 24-h food intake in the two groups to an equal extent at every dose (by 15, 22, and 35%, respectively). These findings support the hypothesis that the effect of uncontrolled diabetes to lower leptin levels contributes to diabetic hyperphagia and that this effect is not due to altered leptin sensitivity.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. M. Lechuga-Sancho, A. I. Arroba, L. M. Frago, C. Garcia-Caceres, A. D.-R. de Celix, J. Argente, and J. A. Chowen
Reduction in the Number of Astrocytes and Their Projections Is Associated with Increased Synaptic Protein Density in the Hypothalamus of Poorly Controlled Diabetic Rats
Endocrinology, November 1, 2006; 147(11): 5314 - 5324.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Dong, T. L. Peeters, B. De Smet, D. Moechars, C. Delporte, P. Vanden Berghe, B. Coulie, M. Tang, and I. Depoortere
Role of Endogenous Ghrelin in the Hyperphagia of Mice with Streptozotocin-Induced Diabetes
Endocrinology, June 1, 2006; 147(6): 2634 - 2642.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E Kim, S Sohn, M Lee, J Jung, R D Kineman, and S Park
Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes
J. Endocrinol., February 1, 2006; 188(2): 263 - 270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Tsubone, T. Masaki, I. Katsuragi, K. Tanaka, T. Kakuma, and H. Yoshimatsu
Leptin downregulates ghrelin levels in streptozotocin-induced diabetic mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1703 - R1706.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Namkoong, M. S. Kim, P. G. Jang, S. M. Han, H. S. Park, E. H. Koh, W. J. Lee, J. Y. Kim, I. S. Park, J. Y. Park, et al.
Enhanced Hypothalamic AMP-Activated Protein Kinase Activity Contributes to Hyperphagia in Diabetic Rats
Diabetes, January 1, 2005; 54(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. W. Gelling, J. Overduin, C. D. Morrison, G. J. Morton, R. S. Frayo, D. E. Cummings, and M. W. Schwartz
Effect of Uncontrolled Diabetes on Plasma Ghrelin Concentrations and Ghrelin-Induced Feeding
Endocrinology, October 1, 2004; 145(10): 4575 - 4582.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. J. Havel
Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism
Diabetes, February 1, 2004; 53(90001): S143 - 151.
[Abstract] [Full Text]


Home page
DiabetesHome page
S. E. la Fleur, H. Ji, S. L. Manalo, M. I. Friedman, and M. F. Dallman
The Hepatic Vagus Mediates Fat-Induced Inhibition of Diabetic Hyperphagia
Diabetes, September 1, 2003; 52(9): 2321 - 2330.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Yang and C. B. Newgard
Hepatic Expression of a Targeting Subunit of Protein Phosphatase-1 in Streptozotocin-diabetic Rats Reverses Hyperglycemia and Hyperphagia Despite Depressed Glucokinase Expression
J. Biol. Chem., June 20, 2003; 278(26): 23418 - 23425.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Liu, Y. Nakagawa, Y. Wang, R. Li, X. Li, T. Ohzeki, and T. C. Friedman
Leptin Activation of Corticosterone Production in Hepatocytes May Contribute to the Reversal of Obesity and Hyperglycemia in Leptin-Deficient ob/ob Mice
Diabetes, June 1, 2003; 52(6): 1409 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C.-Y. Lin, D. A. Higginbotham, R. L. Judd, and B. D. White
Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1084 - E1091.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
P. J. Havel
Peripheral Signals Conveying Metabolic Information to the Brain: Short-Term and Long-Term Regulation of Food Intake and Energy Homeostasis
Experimental Biology and Medicine, December 1, 2001; 226(11): 963 - 977.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M.-D. Chen, V. C. Yang, P. S. Alexander, P.-Y. Lin, and Y.-M. Song
Effects of Selected Minerals on Leptin Secretion in Streptozotocin-Induced Hyperglycemic Mice
Experimental Biology and Medicine, October 1, 2001; 226(9): 836 - 840.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. E. McMinn, D. K. Sindelar, P. J. Havel, and M. W. Schwartz
Leptin Deficiency Induced by Fasting Impairs the Satiety Response to Cholecystokinin
Endocrinology, December 1, 2000; 141(12): 4442 - 4448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. J Havel
Mechanisms regulating leptin production: implications for control of energy balance
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 305 - 306.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.